The off-label use of treatments is especially prevalent in dermatology as the need for effective therapies outpaces the approval process. Experts discuss the most commonly employed treatments, the ethical implications of off-label use, and the need for patient education.
Katlein França, MD, PhD, spoke with Dermatology Advisor about the use of the behavior therapy technique “habit reversal training” (HRT) for the treatment of trichotillomania, excoriation disorder, and itch.
Atopic dermatitis, especially severe atopic dermatitis, is associated with allergic, autoimmune, and cardiovascular comorbidities.
There has been ongoing controversy regarding the relative safety of e-cigarettes vs combustible cigarettes.
Dermatology Advisor interviewed Raja Sivamani, MD, MS, AP, adjunct associate professor of clinical dermatology and director of clinical research at the University of California to discuss the application of ayurvedic medicine in dermatology.
Experts discuss their treatment strategies – and promising therapies – for treatment-resistant atopic dermatitis
According to estimates from the National Institutes of Health, androgenic alopecia affects 30 million women and 50 million men in the United States.